https://selitrectinibinhibitor.....com/marker-developm
Hemophagocytic lymphohistiocytosis (HLH) is a syndrome of excessive immunity activation driven mainly by large degrees of interferon gamma. The clinical presentation of HLH can have substantial overlap along with other inflammatory problems. We present a cohort of patients with therapy refractory HLH referred to the center who had been found to have a simultaneous presentation of complement-mediated thrombotic microangiopathy (TMA). Twenty-three patients had therap
Like
Comment
Share
